NO953461D0 - Faste lipidpartikler, slike partikler omfattende bioaktive midler samt fremstilling og bruk derav - Google Patents
Faste lipidpartikler, slike partikler omfattende bioaktive midler samt fremstilling og bruk deravInfo
- Publication number
- NO953461D0 NO953461D0 NO953461A NO953461A NO953461D0 NO 953461 D0 NO953461 D0 NO 953461D0 NO 953461 A NO953461 A NO 953461A NO 953461 A NO953461 A NO 953461A NO 953461 D0 NO953461 D0 NO 953461D0
- Authority
- NO
- Norway
- Prior art keywords
- particles
- suspensions
- preparation
- lipid
- solid lipid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/044—Suspensions
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
- A01N25/02—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing liquids as carriers, diluents or solvents
- A01N25/04—Dispersions, emulsions, suspoemulsions, suspension concentrates or gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0241—Containing particulates characterized by their shape and/or structure
- A61K8/0245—Specific shapes or structures not provided for by any of the groups of A61K8/0241
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/5123—Organic compounds, e.g. fats, sugars
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5192—Processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F23/00—Mixing according to the phases to be mixed, e.g. dispersing or emulsifying
- B01F23/40—Mixing liquids with liquids; Emulsifying
- B01F23/41—Emulsifying
- B01F23/4105—Methods of emulsifying
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F23/00—Mixing according to the phases to be mixed, e.g. dispersing or emulsifying
- B01F23/40—Mixing liquids with liquids; Emulsifying
- B01F23/48—Mixing liquids with liquids; Emulsifying characterised by the nature of the liquids
- B01F23/482—Mixing liquids with liquids; Emulsifying characterised by the nature of the liquids using molten solids
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F23/00—Mixing according to the phases to be mixed, e.g. dispersing or emulsifying
- B01F23/50—Mixing liquids with solids
- B01F23/51—Methods thereof
- B01F23/511—Methods thereof characterised by the composition of the liquids or solids
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/41—Particular ingredients further characterized by their size
- A61K2800/413—Nanosized, i.e. having sizes below 100 nm
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F23/00—Mixing according to the phases to be mixed, e.g. dispersing or emulsifying
- B01F23/40—Mixing liquids with liquids; Emulsifying
- B01F23/41—Emulsifying
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Nanotechnology (AREA)
- Birds (AREA)
- Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Optics & Photonics (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Environmental Sciences (AREA)
- Dentistry (AREA)
- Toxicology (AREA)
- Plant Pathology (AREA)
- Pest Control & Pesticides (AREA)
- Agronomy & Crop Science (AREA)
- Geometry (AREA)
- Dermatology (AREA)
- Biophysics (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Medicinal Preparation (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Manufacturing Of Micro-Capsules (AREA)
- General Preparation And Processing Of Foods (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US2750193A | 1993-03-05 | 1993-03-05 | |
CA002091152A CA2091152C (en) | 1993-03-05 | 1993-03-05 | Solid lipid particles, particles of bioactive agents and methods for the manfuacture and use thereof |
PCT/SE1994/000185 WO1994020072A1 (en) | 1993-03-05 | 1994-03-04 | Solid lipid particles, particles of bioactive agents and methods for the manufacture and use thereof |
Publications (3)
Publication Number | Publication Date |
---|---|
NO953461D0 true NO953461D0 (no) | 1995-09-04 |
NO953461L NO953461L (no) | 1995-11-06 |
NO314285B1 NO314285B1 (no) | 2003-03-03 |
Family
ID=25675967
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO19953461A NO314285B1 (no) | 1993-03-05 | 1995-09-04 | Fremgangsmåte ved emulgering av uopplöselige eller dårlig opplöselige materialer samt suspensjon dannet ved fremgangsmåten, partikler oganvendelse |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP0687172B1 (no) |
JP (2) | JP3916249B2 (no) |
AT (1) | ATE228821T1 (no) |
AU (1) | AU676279B2 (no) |
CA (1) | CA2091152C (no) |
DE (1) | DE69431831T2 (no) |
DK (1) | DK0687172T3 (no) |
ES (1) | ES2190439T3 (no) |
FI (1) | FI114006B (no) |
NO (1) | NO314285B1 (no) |
NZ (1) | NZ262541A (no) |
PT (1) | PT687172E (no) |
WO (1) | WO1994020072A1 (no) |
Families Citing this family (80)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5885486A (en) * | 1993-03-05 | 1999-03-23 | Pharmaciaand Upjohn Ab | Solid lipid particles, particles of bioactive agents and methods for the manufacture and use thereof |
US5785976A (en) * | 1993-03-05 | 1998-07-28 | Pharmacia & Upjohn Ab | Solid lipid particles, particles of bioactive agents and methods for the manufacture and use thereof |
PT101422B (pt) * | 1993-12-06 | 1997-06-30 | Ineti Inst Biotec Q F E Tecnol | Formulacoes lipossomicas contendo vidarabina e/ou derivados, com indice terapeutico elevado e processo para a sua preparacao |
DE4440337A1 (de) * | 1994-11-11 | 1996-05-15 | Dds Drug Delivery Services Ges | Pharmazeutische Nanosuspensionen zur Arzneistoffapplikation als Systeme mit erhöhter Sättigungslöslichkeit und Lösungsgeschwindigkeit |
US5747001A (en) * | 1995-02-24 | 1998-05-05 | Nanosystems, L.L.C. | Aerosols containing beclomethazone nanoparticle dispersions |
CA2213638C (en) * | 1995-02-24 | 2004-05-04 | Nanosystems L.L.C. | Aerosols containing nanoparticle dispersions |
DE19517147C2 (de) * | 1995-05-10 | 1999-07-01 | Hexal Pharmaforschung Gmbh | Aciclovir-Zubereitung |
US6465016B2 (en) | 1996-08-22 | 2002-10-15 | Research Triangle Pharmaceuticals | Cyclosporiine particles |
KR100542816B1 (ko) * | 1996-08-22 | 2006-01-11 | 알티피 파마 코포레이션 | 수불용성 물질의 미립자를 포함하는 조성물 및 이것의 제조 방법 |
DE19641259A1 (de) * | 1996-10-07 | 1998-04-16 | Kade Pharma Fab Gmbh | Arzneimittel auf Basis von Diclofenac |
JP4155600B2 (ja) | 1996-10-25 | 2008-09-24 | モンサント・テクノロジー・エルエルシー | 外因性化学物質を用いて植物を処置するための化合物及び方法 |
ES2172774T3 (es) * | 1996-10-25 | 2002-10-01 | Monsanto Technology Llc | Composiciones y procedimiento para el tratamiento de plantas con sustancias quimicas exogenas. |
GB9624615D0 (en) * | 1996-11-26 | 1997-01-15 | Zeneca Ltd | Chrystallisation process |
GB9625589D0 (en) * | 1996-12-10 | 1997-01-29 | Boots Co Plc | Therapeutic agents |
IT1292142B1 (it) * | 1997-06-12 | 1999-01-25 | Maria Rosa Gasco | Composizione farmaceutica in forma di microparticelle lipidiche solide atte alla somministrazione parenterale |
US6423363B1 (en) | 1997-08-22 | 2002-07-23 | Lipton, Division Of Conopco, Inc. | Aqueous dispersion |
AU1809499A (en) * | 1997-12-10 | 1999-06-28 | Awadhesh K. Mishra | Self-emulsifying fenofibrate formulations |
IT1298575B1 (it) * | 1998-02-06 | 2000-01-12 | Vectorpharma Int | Composizioni farmaceutiche in forma di nanoparticelle comprendenti sostanze lipidiche e sostanze antifiliche e relativo processo di |
SE512958C2 (sv) † | 1998-04-30 | 2000-06-12 | Triple Crown Ab | Kolesterolsänkande komposition innehållande beta-sitosterol och/eller beta-sitostanol samt förfarande för dess framställning |
GB9810859D0 (en) | 1998-05-20 | 1998-07-22 | Zeneca Ltd | Crystallisation process |
ATE258008T1 (de) * | 1998-06-17 | 2004-02-15 | Uniroyal Chem Co Inc | Biologisch aktive mikrodispersionszusammensetzung |
ITMI981528A1 (it) * | 1998-07-03 | 2000-01-03 | Recordati Ind Chimica E Farma | Formulazioni topiche di aciclovir |
US7521068B2 (en) | 1998-11-12 | 2009-04-21 | Elan Pharma International Ltd. | Dry powder aerosols of nanoparticulate drugs |
AU767154B2 (en) | 1998-11-20 | 2003-10-30 | Skyepharma Canada Inc. | Dispersible phospholipid stabilized microparticles |
IT1303787B1 (it) * | 1998-11-25 | 2001-02-23 | Maria Rosa Gasco | "nanosfere lipidiche solide atte ad una rapida internalizzazione nellecellule" |
DE19919770A1 (de) * | 1999-04-30 | 2000-11-02 | Henkel Kgaa | Verwendung nanoskaliger antimikrobieller Wirkstoffe in der Mund- und/oder Zahnpflege |
SE517769C2 (sv) | 1999-10-29 | 2002-07-16 | Triple Crown Ab | Kolesterol och blodfettsänkande komposition, innehållande fytosteroler, blandade med monoglycerider |
KR20020026053A (ko) | 2000-09-30 | 2002-04-06 | 노승권 | 음료용 식물성 스테롤의 분산방법 및 이를 함유하는 음료 |
US20040077604A1 (en) | 2001-12-19 | 2004-04-22 | Lenard Lichtenberger | Method and compositions employing formulations of lecithin oils and nsaids for protecting the gastrointestinal tract and providingenhanced therapeutic activity |
US9700866B2 (en) | 2000-12-22 | 2017-07-11 | Baxter International Inc. | Surfactant systems for delivery of organic compounds |
US8067032B2 (en) | 2000-12-22 | 2011-11-29 | Baxter International Inc. | Method for preparing submicron particles of antineoplastic agents |
BR0212833A (pt) | 2001-09-26 | 2004-10-13 | Baxter Int | Preparação de nanopartìculas de tamanho submìcron através de dispersão e de remoção de solvente ou de fase lìquida |
US20060003012A9 (en) | 2001-09-26 | 2006-01-05 | Sean Brynjelsen | Preparation of submicron solid particle suspensions by sonication of multiphase systems |
EP1480661B1 (de) | 2002-02-28 | 2011-04-13 | Heitland & Petre International GmbH | Mikro-/nanopartikel aus lipidhaltigen marinen organismen für pharmazie und kosmetik |
AU2002241368B2 (en) * | 2002-03-20 | 2009-07-09 | Eugene Science Inc. | Plant sterol-containing food, and method for preparing the same |
JP4452970B2 (ja) | 2002-03-27 | 2010-04-21 | 日本臓器製薬株式会社 | ジクロフェナクナトリウム経口製剤 |
US20040258757A1 (en) * | 2002-07-16 | 2004-12-23 | Elan Pharma International, Ltd. | Liquid dosage compositions of stable nanoparticulate active agents |
ITMI20021725A1 (it) * | 2002-08-01 | 2002-10-31 | Zambon Spa | Composizioni farmaceutiche ad attivita' antibiotica. |
JP2006524632A (ja) | 2002-12-09 | 2006-11-02 | アメリカン バイオサイエンス、インコーポレイテッド | 組成物及び薬物送達方法 |
DE10312763A1 (de) * | 2003-03-21 | 2004-09-30 | IFAC Institut für angewandte Colloidtechnologie GmbH & Co. KG | Verfahren zur Herstellung einer SLN-Dispersion |
FR2852843B1 (fr) | 2003-03-24 | 2008-05-23 | Karim Ioualalen | Systeme galenique permettant le masquage du gout |
JP2004323444A (ja) * | 2003-04-25 | 2004-11-18 | Hamamatsu Kagaku Gijutsu Kenkyu Shinkokai | 凍結乾燥微粒子製剤およびその製法 |
US7438903B2 (en) | 2003-06-06 | 2008-10-21 | Nbty, Inc. | Methods and compositions that enhance bioavailability of coenzyme-Q10 |
JP2007503418A (ja) | 2003-08-27 | 2007-02-22 | バイヤースドルフ・アクチエンゲゼルシヤフト | 局所使用中に個別には感知不能になる外皮を有するカプセル |
DE10357639A1 (de) | 2003-08-27 | 2005-03-24 | Beiersdorf Ag | Kosmetische und/oder dermatologische Kapsel |
US8741320B2 (en) | 2003-08-27 | 2014-06-03 | Beiersdorf Ag | Spherical cosmetic preparations for topical application |
JP2005097295A (ja) * | 2003-09-01 | 2005-04-14 | Wakunaga Pharmaceut Co Ltd | ビタミン安定液剤 |
US7611733B2 (en) | 2004-03-26 | 2009-11-03 | Cell Therapeutics Europe S.R.L. | Nanoparticle formulations of platinum compounds |
US7803366B2 (en) | 2004-05-07 | 2010-09-28 | Nbty, Inc. | Methods and compositions that enhance bioavailability of coenzyme-Q10 |
EP1674085A1 (en) * | 2004-12-22 | 2006-06-28 | Universite Libre De Bruxelles | Solid lipidic particles as pharmaceutically acceptable fillers or carriers for inhalation |
KR20130079645A (ko) * | 2005-07-18 | 2013-07-10 | 유니버시티 오브 메사츄세츠 로웰 | 나노에멀젼 조성물 및 이의 제조 및 사용 방법 |
US9486408B2 (en) | 2005-12-01 | 2016-11-08 | University Of Massachusetts Lowell | Botulinum nanoemulsions |
US7943666B2 (en) | 2006-07-24 | 2011-05-17 | Trinity Laboratories, Inc. | Esters of capsaicin for treating pain |
SG177184A1 (en) | 2006-12-01 | 2012-01-30 | Anterios Inc | Amphiphilic entity nanoparticles |
BRPI0719732A2 (pt) | 2006-12-01 | 2017-05-16 | Anterios Inc | nanopartículas de peptídeo e usos para as mesmas |
WO2008102065A1 (fr) * | 2007-02-14 | 2008-08-28 | Commissariat A L'energie Atomique | Emulsions fluorescentes pour l'imagerie optique |
EP3398611B1 (en) | 2007-04-18 | 2020-08-12 | Particle Sciences, Inc. | Aerosol dispersions of particles with active pharmaceutical ingredients |
CN103961315A (zh) | 2007-05-31 | 2014-08-06 | 安特里奥公司 | 核酸纳米粒子和其用途 |
JP5468271B2 (ja) * | 2008-02-08 | 2014-04-09 | 花王株式会社 | 微粒子分散液の製造方法 |
DE102008035442A1 (de) | 2008-07-26 | 2010-01-28 | Ernst-Moritz-Arndt-Universität Greifswald | Zubereitungen aus Artemisia Annua, ihre Umwandlung in Mikro- und Nanopartikel und ihre Verwendung |
FR2934953B1 (fr) | 2008-08-14 | 2011-01-21 | Commissariat Energie Atomique | Nanoemulsions de nanocristaux |
FR2934954B1 (fr) * | 2008-08-14 | 2011-07-22 | Commissariat Energie Atomique | Emulsion fluorescente de vert d'indocyanine |
FR2934955B1 (fr) | 2008-08-14 | 2011-07-08 | Commissariat Energie Atomique | Encapsulation d'agents therapeutiques lipophiles ou amphiphiles dans des nanoemulsions |
RU2535017C2 (ru) | 2008-09-19 | 2014-12-10 | Активус Фарма Ко., Лтд. | Композитный порошок из органического вещества для применения в медицине, способ его получения и его суспензия |
CA2763456C (en) | 2009-05-27 | 2017-10-24 | Alkermes Pharma Ireland Limited | Reduction of flake-like aggregation in nanoparticulate active agent compositions |
WO2011139899A2 (en) | 2010-05-03 | 2011-11-10 | Teikoku Pharma Usa, Inc. | Non-aqueous taxane pro-emulsion formulations and methods of making and using the same |
WO2012059936A1 (en) | 2010-11-03 | 2012-05-10 | Padma Venkitachalam Devarajan | Pharmaceutical compositions for colloidal drug delivery |
WO2013105026A1 (en) * | 2012-01-09 | 2013-07-18 | Department Of Biotechnology (Dbt) | A process for preparing solid lipid sustained release nanoparticles for delivery of vitamins |
JO3685B1 (ar) | 2012-10-01 | 2020-08-27 | Teikoku Pharma Usa Inc | صيغ التشتيت الجسيمي للتاكسين غير المائي وطرق استخدامها |
WO2014054172A1 (ja) * | 2012-10-05 | 2014-04-10 | 株式会社原田食品 | ゾル状低カロリー食品素材および包装容器体入ゾル状低カロリー食品素材およびそれらの製造方法 |
CN104822372A (zh) * | 2012-11-30 | 2015-08-05 | 英斯梅德股份有限公司 | 前列环素组合物及其使用方法 |
EP2823811A1 (en) * | 2013-07-09 | 2015-01-14 | OTC GmbH | Targeted active release system comprising solid lipid nano-particles |
CA2927788C (en) | 2013-10-25 | 2022-09-06 | Insmed Incorporated | Prostacyclin compounds, compositions and methods of use thereof |
IN2014CH01872A (no) | 2014-04-09 | 2015-05-08 | Nanoceutica Lab Pvt Ltd | |
WO2016081658A1 (en) | 2014-11-18 | 2016-05-26 | Insmed Incorporated | Methods of manufacturing treprostinil and treprostinil derivative prodrugs |
CN110225975A (zh) | 2016-08-23 | 2019-09-10 | 阿库斯股份有限公司 | 用于治疗人受试者中非年龄相关的听力损害的组合物和方法 |
AU2017360346B2 (en) | 2016-11-21 | 2023-11-23 | Eirion Therapeutics, Inc. | Transdermal delivery of large agents |
CA3138530A1 (en) | 2019-04-29 | 2020-11-05 | Insmed Incorporated | Dry powder compositions of treprostinil prodrugs and methods of use thereof |
CN114867363A (zh) * | 2019-12-10 | 2022-08-05 | 比利时胶囊公司 | 含脂质基质核心和活性成分的颗粒 |
JP2023515072A (ja) | 2020-02-21 | 2023-04-12 | アコーオス インコーポレイテッド | ヒト対象において非加齢関連聴力障害を処置するための組成物および方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3421468A1 (de) * | 1984-06-08 | 1985-12-19 | Dr. Rentschler Arzneimittel Gmbh & Co, 7958 Laupheim | Lipidnanopellets als traegersystem fuer arzneimittel zur peroralen anwendung |
DE3702029A1 (de) * | 1987-01-24 | 1988-08-04 | Basf Ag | Waessriges oder pulverfoermiges, wasserdispergierbares praeparat eines in wasser schwerloeslichen pharmazeutischen wirkstoffs und verfahren zu seiner herstellung |
DK0502119T3 (da) * | 1989-11-13 | 1996-06-03 | Abraham J Domb | Liposfærer til kontrolleret frigivelse af substanser |
AU658608B2 (en) * | 1991-03-25 | 1995-04-27 | Astellas Pharma Europe B.V. | Topical preparation containing a suspension of solid lipid particles |
-
1993
- 1993-03-05 CA CA002091152A patent/CA2091152C/en not_active Expired - Fee Related
-
1994
- 1994-03-04 JP JP51988794A patent/JP3916249B2/ja not_active Expired - Fee Related
- 1994-03-04 NZ NZ262541A patent/NZ262541A/en unknown
- 1994-03-04 WO PCT/SE1994/000185 patent/WO1994020072A1/en active IP Right Grant
- 1994-03-04 AU AU62253/94A patent/AU676279B2/en not_active Ceased
- 1994-03-04 AT AT94909393T patent/ATE228821T1/de not_active IP Right Cessation
- 1994-03-04 EP EP94909393A patent/EP0687172B1/en not_active Expired - Lifetime
- 1994-03-04 DK DK94909393T patent/DK0687172T3/da active
- 1994-03-04 PT PT94909393T patent/PT687172E/pt unknown
- 1994-03-04 DE DE69431831T patent/DE69431831T2/de not_active Expired - Fee Related
- 1994-03-04 ES ES94909393T patent/ES2190439T3/es not_active Expired - Lifetime
-
1995
- 1995-09-04 NO NO19953461A patent/NO314285B1/no unknown
- 1995-09-04 FI FI954143A patent/FI114006B/fi not_active IP Right Cessation
-
2006
- 2006-09-27 JP JP2006261728A patent/JP2007023051A/ja not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO1994020072A1 (en) | 1994-09-15 |
FI954143A (fi) | 1995-10-19 |
PT687172E (pt) | 2003-04-30 |
JP2007023051A (ja) | 2007-02-01 |
DE69431831D1 (de) | 2003-01-16 |
JP3916249B2 (ja) | 2007-05-16 |
JPH08507515A (ja) | 1996-08-13 |
AU676279B2 (en) | 1997-03-06 |
DE69431831T2 (de) | 2003-04-10 |
FI954143A0 (fi) | 1995-09-04 |
EP0687172B1 (en) | 2002-12-04 |
NO953461L (no) | 1995-11-06 |
ES2190439T3 (es) | 2003-08-01 |
AU6225394A (en) | 1994-09-26 |
CA2091152C (en) | 2005-05-03 |
NO314285B1 (no) | 2003-03-03 |
EP0687172A1 (en) | 1995-12-20 |
ATE228821T1 (de) | 2002-12-15 |
FI114006B (fi) | 2004-07-30 |
CA2091152A1 (en) | 1994-09-06 |
DK0687172T3 (da) | 2003-03-17 |
NZ262541A (en) | 1997-04-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO953461L (no) | Faste lipidpartikler, slike partikler omfattende bioaktive midler samt fremstilling og bruk derav | |
Benoit et al. | Preparation and characterization of protein-loaded poly (ε-caprolactone) microparticles for oral vaccine delivery | |
Swaan | Recent advances in intestinal macromolecular drug delivery via receptor-mediated transport pathways | |
AR010758A1 (es) | Composicion de ibuprofeno que comprende uno o mas medicamentos, preparacion acuosa de dosis unitaria, proceso para preparar dicha preparacion acuosa,proceso para preparar dicha composicion de ibuprofeno, y uso de dicha preparacion | |
Latha et al. | Progesterone release from glutaraldehyde cross-linked casein microspheres: in vitro studies and in vivo response in rabbits | |
GB2237510B (en) | Small particle drug compositions for nasal administration | |
JP2594560B2 (ja) | 巨大分子ポリペプチドの放出速度調節 | |
Menei et al. | Drug targeting into the central nervous system by stereotactic implantation of biodegradable microspheres | |
DK0711151T3 (da) | Partikler med modificerede fysisk-kemiske egenskaber, deres fremstilling og anvendelser | |
WO2001035932A3 (en) | Sustained drug delivery from structural matrices | |
FI102811B1 (fi) | Menetelmä vaikuttavaa ainetta sisältävien mikropartikkeleiden valmistamiseksi hydrolyyttisesti hajoavista polymeereistä | |
CA2292586A1 (en) | Solid pharmaceutical dosage forms in form of a particulate dispersion | |
DE69428040D1 (de) | Orale darreichungsform | |
CN101801358A (zh) | 治疗性稳定的纳米颗粒 | |
MXPA06011171A (es) | Aplicacion ex-vivo de agentes terapeuticos microparticulados solidos. | |
Raghuvanshi et al. | Stabilization of dichloromethane-induced protein denaturation during microencapsulation | |
NL300330I2 (nl) | Preparaat voor het afgeven van peptiden | |
JPH062224B2 (ja) | 極小粒子形の蛋白質の分散性コロイド系の調製方法 | |
Byeon et al. | PEGylated apoptotic protein-loaded PLGA microspheres for cancer therapy | |
DE60018629D1 (de) | Carbamazepinformulierung mit verzögerter Freigabe | |
US20040146564A1 (en) | Process for making delivery matrix and uses thereof | |
JP2789115B2 (ja) | 可溶性コラーゲンパウダーを担体とする粒状医薬徐放剤の製造方法 | |
Beyatricks et al. | RECENT TRENDS IN MICROSPHERE DRUG DELIVERY SYSTEM AND ITS THERAPEUTIC APPLICATIONS–A | |
Agrawal et al. | Parenteral delivery of peptides and proteins | |
WO2000013666A1 (en) | Biodegradable particulate polymeric preparation and process for producing thereof |